Company Filing History:
1 out of 4 
1 out of 5,081 
1 out of 1,743 
Years Active: 2015
Title: Rabia Sadir: Innovator in Influenza Treatment
Introduction
Rabia Sadir is a notable inventor based in I'Albenc, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases caused by the influenza virus. Her innovative work has led to the development of a unique patent that showcases her expertise in polysaccharides.
Latest Patents
Rabia Sadir holds a patent for "Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus." This invention relates to polysaccharides that are intended to be used as a drug for the preventive or curative treatment of influenza. The patent also includes pharmaceutical compositions that combine these polysaccharides with at least one pharmaceutically acceptable carrier.
Career Highlights
Throughout her career, Rabia has worked with esteemed organizations such as Elicityl and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Rabia has collaborated with notable professionals, including Bruno Lina and Olivier Ferraris. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Rabia Sadir is a pioneering inventor whose work in influenza treatment exemplifies her dedication to advancing medical science. Her contributions through her patent and collaborations highlight her significant role in the field.